127 related articles for article (PubMed ID: 34331990)
1. Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients.
Shoraka S; Mohebbi SR; Hosseini SM; Asadzadeh Aghdaei H; Zali MR
Virus Res; 2021 Oct; 303():198503. PubMed ID: 34331990
[TBL] [Abstract][Full Text] [Related]
2. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-
Yao J; Lin C; Jiang J; Zhang X; Li F; Liu T; Diao H
Front Immunol; 2021; 12():666370. PubMed ID: 34168644
[TBL] [Abstract][Full Text] [Related]
3. Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis.
Fu N; Niu X; Wang Y; Du H; Wang B; Du J; Li Y; Wang R; Zhang Y; Zhao S; Sun D; Qiao L; Nan Y
Discov Med; 2016 Aug; 22(119):29-42. PubMed ID: 27585228
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of LncRNA-MEG3 as a serum biomarker in patients with hepatitis B complicated with liver fibrosis.
Chen MJ; Wang XG; Sun ZX; Liu XC
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4360-4367. PubMed ID: 31173310
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection.
Guo Y; Li C; Zhang R; Zhan Y; Yu J; Tu J; Zheng J
Cancer Biomark; 2021; 32(2):137-146. PubMed ID: 34092613
[TBL] [Abstract][Full Text] [Related]
6. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study.
Ma J; Cui X; Rong Y; Zhou Y; Guo Y; Zhou M; Xiao L; Chen W
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556453
[TBL] [Abstract][Full Text] [Related]
7. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
8. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA (LncRNA)-ATB Promotes Inflammation, Cell Apoptosis and Senescence in Transforming Growth Factor-β1 (TGF-β1) Induced Human Kidney 2 (HK-2) Cells via TGFβ/SMAD2/3 Signaling Pathway.
Sun H; Ke C; Zhang L; Tian C; Zhang Z; Wu S
Med Sci Monit; 2020 May; 26():e922029. PubMed ID: 32447340
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
Wang PC; Wei TY; Tseng TC; Lin HH; Wang CC
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):946-950. PubMed ID: 28538267
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.
Piao RL; Brigstock DR; Zhu J; Zhang ML; Gao RP
World J Gastroenterol; 2012 May; 18(18):2280-6. PubMed ID: 22611323
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
15. Identification and clinical significance of an elevated level of serum aminoacylase-1 autoantibody in patients with hepatitis B virus-related liver cirrhosis.
He X; Hong Y; Wang X; Zhang X; Long J; Li H; Zhang B; Chen S; Liu Q; Li H; Wang X; Ou X; Huang J
Mol Med Rep; 2016 Nov; 14(5):4255-4262. PubMed ID: 27633755
[TBL] [Abstract][Full Text] [Related]
16. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of acute hepatitis E super-infections on chronic hepatitis B.
Chen C; Zhang SY; Zhang DD; Li XY; Zhang YL; Li WX; Yan JJ; Wang M; Xun JN; Lu C; Ling Y; Huang YX; Chen L
World J Gastroenterol; 2016 Dec; 22(47):10388-10397. PubMed ID: 28058019
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study.
Zhu M; Han M; Xiao X; Lu S; Guan Z; Song Y; Liu C
Int J Med Sci; 2019; 16(5):720-728. PubMed ID: 31217740
[No Abstract] [Full Text] [Related]
19. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
[TBL] [Abstract][Full Text] [Related]
20. Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.
Chu CM; Lin CC; Chen YC; Jeng WJ; Lin SM; Liaw YF
Br J Cancer; 2012 Dec; 107(12):2010-5. PubMed ID: 23079574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
